SEP 08, 2015 04:28 PM PDT

Diabetes and Alzheimer's

People who have type 2 diabetes could be at greater risk for the buildup of tangles of protein in their spinal fluid, irrespective of dementia, according to a new study published in Neurology and reported by Bevin Fletcher in Bioscience Technology. Led by researchers at Monash University in Melbourne, Australia, the study observed the relationship between type 2 diabetes, the levels of beta amyloid and tau protein in the spinal fluid and the loss of brain cells and their connection.
Study links diabetes to protein tangles. 
The study included 816 participants, of which 124 had diabetes, 397 had mild cognitive impairment, 191 had Alzheimer’s disease and 228 had no memory and thinking problems. The average age of the study participants was 74.
 
On average, participants who had diabetes exhibited16 picograms per milliliter greater levels of the tau protein in the spinal and brain fluid, regardless of whether or not they suffered from dementia, which may reflect a greater buildup of tangles in the brain.
 
According to study author Velandai Srikanth, M.D., Ph.D., “Evidence shows that people with type 2 diabetes have double the risk of developing dementia. This interesting development further defines how the diseases may be connected.”
 
The study related that the accumulation of tangles may also contribute to the loss of brain tissue. Additionally, diabetes was associated with an average of 0.03 millimeter less cortical tissue in brains of participants who had diabetes than those who did not.
 
Srikanth explained that because of the fact that nerve cells in the brain fail to replace themselves, “It is extremely important to find ways to reduce the death of current brain cells. Studies such as ours seek to understand how diseases like diabetes may directly or indirectly affect brain cell death.”
 
The study did not determine a cause-and-effect relationship between diabetes and brain tangles.
 
Researchers from the Mayo Clinic have made the case for a link between type 2 diabetes and Alzheimer’s disease, labeling Alzheimer’s disease “type 3 diabetes.” Their studies show that people with diabetes, especially type 2 diabetes, are at higher risk for eventually developing Alzheimer's disease or other dementias. 
About the Author
  • Ilene Schneider is the owner of Schneider the Writer, a firm that provides communications for health care, high technology and service enterprises. Her specialties include public relations, media relations, advertising, journalistic writing, editing, grant writing and corporate creativity consulting services. Prior to starting her own business in 1985, Ilene was editor of the Cleveland edition of TV Guide, associate editor of School Product News (Penton Publishing) and senior public relations representative at Beckman Instruments, Inc. She was profiled in a book, How to Open and Operate a Home-Based Writing Business and listed in Who's Who of American Women, Who's Who in Advertising and Who's Who in Media and Communications. She was the recipient of the Women in Communications, Inc. Clarion Award in advertising. A graduate of the University of Pennsylvania, Ilene and her family have lived in Irvine, California, since 1978.
You May Also Like
SEP 22, 2019
Cell & Molecular Biology
SEP 22, 2019
Why Sleep is Good for Us
Animals spend a lot of their lifetime asleep, and scientists have sought to understand the physiological purpose of all that spent time....
SEP 22, 2019
Drug Discovery & Development
SEP 22, 2019
Antidepressants May Impair Empathy
Depression is tagged with strong impairments of social functioning. Until recently, researchers believed that acute depression impairs empathy—a nece...
SEP 22, 2019
Drug Discovery & Development
SEP 22, 2019
Drug Targets Early Instigators of Alzheimer Disease
The two solidifying instigators of Alzheimer -disease (AD)—amyloid beta and the tau protein—have long been the topic of study for AD researcher...
SEP 22, 2019
Drug Discovery & Development
SEP 22, 2019
Can FDA Approved Ketamine Drug Spravato Really Treat Depression?
President Trump is allegedly in support of a new drug to combat depression. He even urged the Department of Veterans Affairs to purchase it and “get ...
SEP 22, 2019
Chemistry & Physics
SEP 22, 2019
Scientists Developed Magnetic Nanoparticles that can Remotely Modulate Neural Circuits
Currently, neuroscience researchers rely heavily on invasive procedures to stimulate and study the neural activity of animals. A team of MIT scientists has...
SEP 22, 2019
Plants & Animals
SEP 22, 2019
These Are Some of Nature's Brightest Animals
Lots of people are quick to dismiss animal intelligence as inferior to human intelligence, but let the record show that plenty of animals have earned a rep...
Loading Comments...